Jeffrey Neul Archive — Page 1 of 1

January 9, 2024

VUMC receives $13 million grant to coordinate multisite clinical trial for Rett syndrome treatment

Vanderbilt University Medical Center received a $13 million Department of Defense grant to lead a multisite clinical trial that will evaluate repurposed FDA-approved drugs as treatment options for patients with Rett syndrome.

By Danny Bonvissuto

July 7, 2023

Rett syndrome drug studied at Vanderbilt approved for patients

The first drug to treat the symptoms of Rett syndrome was recently approved, following a Nature Medicine study publishing results from the pivotal phase 3 LAVENDER study led by investigators from Vanderbilt University Medical Center to evaluate efficacy and safety of trofinetide.

By Craig Boerner

December 6, 2021

Potential Rett syndrome drug shows promising results in phase 3 trial

A potential first-of-its-kind drug to treat the symptoms of Rett syndrome received positive top-line results from a phase 3 trial led by investigators from Vanderbilt University Medical Center to evaluate efficacy and safety.

By Craig Boerner

Head-and-shoulders portrait of a smiling woman with shoulder-length auburn hair, wearing a bright pink cardigan and black beaded necklace against a softly blurred brown background.

July 30, 2021

Kennedy Center efforts enhance inclusivity in clinical trials

Following the Vanderbilt Kennedy Center’s (VKC) renewal as a national Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center in 2020, the center underwent a shuffling of their four scientific cores that support basic and applied research on intellectual and developmental disabilities (IDD).

By Emily Stembridge

Exterior entrance of a brick-and-concrete campus building, with broad stairs, tall columns, leafy trees, and four vertical banners featuring photographs and small text.

August 20, 2020

Kennedy Center receives grant to continue as IDDRC

The Vanderbilt Kennedy Center (VKC) has been awarded a $6.8 million, five-year grant to continue as a national Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center (IDDRC).

By Courtney Taylor

June 6, 2019

Treating core Rett syndrome symptoms

A new study published in Neurology reports the drug trofinetide has proven safe and effective in treating core symptoms of Rett syndrome in female children and adolescents.

By Kelsey Herbers

October 25, 2018
Grant to help explore critical issues in Down syndrome

The Vanderbilt Kennedy Center (VKC) has received a one-year $604,000 grant from the National Institute of Child Health and Human Development (NICHD) to use Vanderbilt University Medical Center electronic medical record information and biological samples to develop a deeper understanding of critical issues in Down syndrome and to provide an infrastructure for future analyses.
By Jan Rosemergy
March 7, 2017
Neul named new director of the Vanderbilt Kennedy Center

Jeffrey Neul, M.D., Ph.D., division head of Child Neurology and vice chair for Developmental Neurosciences at the University of California, San Diego, has been named the new director of the Vanderbilt Kennedy Center. He will join Vanderbilt on Aug. 1.
By John Howser
December 13, 2016
Rett syndrome expert Neul to speak at Kennedy Center on Friday

Jeffrey Neul, M.D., Ph.D., division head of Child Neurology and vice chair for Developmental Neurosciences at the University of California, San Diego, will present a lecture on Friday, Dec. 16, at Vanderbilt Kennedy Center (VKC).
By Vanderbilt Health News